No Carolina / NY / Florida
Ph: 561.316.3330

Spinal Navigation and Robotics System Receives 510(k) Clearance: Company Plans to Commercialize Across the U.S. in 2021

Summation

  • Fusion Robotics Chief Medical Officer, Kevin Foley, MD commented that “Since the introduction of robotics in spine surgery, the questions of economics and efficiency have hindered the widespread adoption of this technology.
  • With this clearance, and the rapid development of our fluoroscopy-integrated system, we’re working quickly towards making robotics available to many more surgeons, in a form better suited to their practices.
  • Next, we look forward to partnering with clinicians and hospitals to increase efficiency, reduce cost and broadly expand the application of robotics to treat patients.

February 26, 2021

Spinal Navigation and Robotics System by Fusion Robotics, addresses the key limitations of current spinal navigation and robotics systems by offering greater procedural efficiency with significantly less expense.

“We appreciate the partnership developed with FDA to rigorously validate safety and accuracy. Next, we look forward to partnering with clinicians and hospitals to increase efficiency, reduce cost and broadly expand the application of robotics to treat patients.” Said Brad Clayton, CEO of Fusion Robotics.

Fusion Robotics Chief Medical Officer, Kevin Foley, MD commented that “Since the introduction of robotics in spine surgery, the questions of economics and efficiency have hindered the widespread adoption of this technology. With this clearance, and the rapid development of our fluoroscopy-integrated system, we’re working quickly towards making robotics available to many more surgeons, in a form better suited to their practices.”

 

Other FDA News of Interest

Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B

Intuity Medical, Inc., a medical technology company committed to making it easier to live with diabetes, announced today that its POGO Automatic® Blood Glucose...

XT-Thrive® Drug Master File (DMF) Accepted by the FDA | Reports X-Therma

X-Therma notes this DMF covers the Chemistry, Manufacturing and Controls (CMC) for this key chemistry innovation, which enables non-toxic cryopreservation for life-saving regenerative medicines.

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte™ Image Guided Crossing and Re-Entry Catheter System

Simpson Interventions is committed to collaborating closely with the FDA and other stakeholders to advance the development and regulatory review of the Acolyte Image Guided Crossing and Re-Entry Catheter System. The company looks forward to bringing this revolutionary technology to clinicians, and patients in need.

spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy